anmelden
BX Swiss TOP 30 CHF
1.480,29
PKT
-6,17
PKT
-0,42
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 02.08.12 | UBS halten | Independent Research GmbH | |
| 02.08.12 | UBS outperform | Keefe, Bruyette & Woods, Inc. | |
| 01.08.12 | UBS buy | Goldman Sachs Group Inc. | |
| 01.08.12 | UBS neutral | Goldman Sachs Group Inc. | |
| 01.08.12 | UBS overweight | J.P. Morgan Cazenove | |
| 01.08.12 | UBS hold | Société Générale Group S.A. (SG) | |
| 01.08.12 | Holcim outperform | Exane-BNP Paribas SA | |
| 01.08.12 | UBS buy | Nomura | |
| 01.08.12 | UBS underperform | Exane-BNP Paribas SA | |
| 31.07.12 | UBS neutral | Sarasin Research | |
| 31.07.12 | UBS hold | ING | |
| 31.07.12 | Adecco SA buy | Vontobel Research | |
| 31.07.12 | UBS buy | Vontobel Research | |
| 30.07.12 | UBS overweight | HSBC | |
| 30.07.12 | Holcim buy | UBS AG | |
| 30.07.12 | Swisscom outperform | Exane-BNP Paribas SA | |
| 30.07.12 | ABB (Asea Brown Boveri) neutral | Exane-BNP Paribas SA | |
| 30.07.12 | Novartis hold | Vontobel Research | |
| 27.07.12 | Logitech outperform | Exane-BNP Paribas SA | |
| 27.07.12 | Swiss Re neutral | Exane-BNP Paribas SA | |
| 27.07.12 | Roche outperform | Exane-BNP Paribas SA | |
| 27.07.12 | Logitech neutral | UBS AG | |
| 27.07.12 | ABB (Asea Brown Boveri) hold | Société Générale Group S.A. (SG) | |
| 27.07.12 | Logitech hold | Vontobel Research | |
| 26.07.12 | UBS hold | ING | |
| 26.07.12 | Sika neutral | Sarasin Research | |
| 26.07.12 | Logitech neutral | Sarasin Research | |
| 26.07.12 | ABB (Asea Brown Boveri) hold | ING | |
| 26.07.12 | Lonza neutral | UBS AG | |
| 26.07.12 | Straumann neutral | UBS AG | |
| 26.07.12 | Lonza hold | Vontobel Research | |
| 26.07.12 | Logitech hold | Vontobel Research | |
| 26.07.12 | Sika hold | Vontobel Research | |
| 26.07.12 | ABB (Asea Brown Boveri) buy | Vontobel Research | |
| 25.07.12 | UBS outperform | Exane-BNP Paribas SA | |
| 25.07.12 | Lonza neutral | Sarasin Research | |
| 25.07.12 | UBS neutral | Nomura | |
| 25.07.12 | Novartis buy | Nomura | |
| 25.07.12 | Roche kaufen | Sarasin Research | |
| 25.07.12 | Novartis kaufen | Sarasin Research |